News
MONTRÉAL, Aug. 21, 2025 (GLOBE NEWSWIRE) -- GURU Organic Energy Corp. (TSX: GURU) (“ GURU ” or the “ Company ”), Canada’s ...
Expanding access through iCapital represents a meaningful step in bringing actively managed crypto income strategies into the workflows that financial professionals trust,” said Grayscale’s Head of ...
About NARCAN® Nasal Spray NARCAN ® Naloxone HCl Nasal Spray 4 mg is the first FDA-approved, over-the-counter (OTC) 4 mg naloxone product for the emergency treatment of opioid overdose. NARCAN ® Nasal ...
SANTOS, Brazil, Aug. 21, 2025 (GLOBE NEWSWIRE) -- DP World has been awarded the Gold Seal from the Brazilian GHG Protocol Program for the second year running, recognizing the company’s commitment to ...
Miami, FL, Aug. 21, 2025 (GLOBE NEWSWIRE) -- ONAR Holding Corporation (OTCQB: ONAR), an AI-powered marketing agency network, today announced financial results for the second quarter ended June 30, ...
The agreement grants AERXIO exclusive distribution rights to Micropolis's flagship platform, The Patrol, engineered for open-road and desert operations with speeds up to 50km/h, 15-hour runtime, rapid ...
RMS pricing experts continually analyze the impact of macroeconomic indicators on the restaurant industry. This comprehensive, data-driven approach enables operators to anticipate market shifts and ...
“The financial system of the past is rapidly changing and evolving from fiat currencies to the digital era,” said Paul Marino, Chief Revenue Officer of Themes ETFs. “Our New Offerings allow investors ...
Empeon now offers access to The Work Number ® from Equifax ®, enabling automated and more secure income and employment verifications. The Work Number ® helps simplify and accelerate the verification ...
By automatically compressing and compiling AI models, CLIKA enables compact, accelerated, and hardware-ready deployment — across cloud, on-prem, and edge environments. Models are optimized for ...
Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that the U.S. Food and Drug Administration (FDA) granted Orphan Drug Designation (ODD) for atumelnant, a novel, once-daily oral ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results